Patents/Assignees

Entrada Therapeutics, Inc.

2 patents in portfolio

US12378267utility2025
Synthesis of Fmoc-protected Morpholino Monomers and Oligomers
0 cites
US11987821utility2024
Compositions and Methods for Treating Mitochondrial Neurogastrointestinal Encephalopathy
0 cites